ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
1 hedge funds and large institutions have $1K invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more capital invested
Capital invested by funds: $1K → $1K ($0)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
ECTE Hedge Fund Activity: Q2 2017 in Review
1 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q2 2017, worth a combined $1K — unchanged from a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ECTE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
- 1 institutional investor held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q2 2017, down from 2 in Q1 2017.
- Funds reported $1K of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q2 2017, unchanged quarter-over-quarter.
- 0 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q2 2017 and 1 closed out, a net change of -1 holder.
Based on aggregated 13F filings for Q2 2017.